triazoles has been researched along with Complications, Hematologic Pregnancy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agapidou, A; Diamantidis, MD; Fotiou, P; Manafas, A; Neokleous, N; Vetsiou, E; Vlachaki, E | 1 |
Drosou, M; Servos, P; Vini, D | 1 |
Cinque, P; Costantini, S; Di Matola, T; Prossomariti, L; Ricchi, P; Spasiano, A | 1 |
Abbate, G; Anastasi, S; Caruso, V; De Sanctis, V; Giovannini, M; Lisi, R | 1 |
4 other study(ies) available for triazoles and Complications, Hematologic Pregnancy
Article | Year |
---|---|
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Female; Fetus; Humans; Infant, Newborn; Iron Chelating Agents; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pyridones; Triazoles | 2016 |
Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®).
Topics: Adult; Benzoates; beta-Thalassemia; Contraindications; Deferasirox; Female; Humans; Infant, Newborn; Iron Chelating Agents; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Triazoles | 2011 |
A case of well-tolerated and safe deferasirox administration during the first trimester of a spontaneous pregnancy in an advanced maternal age thalassemic patient.
Topics: Administration, Oral; Adult; Benzoates; beta-Thalassemia; Deferasirox; Female; Humans; Iron Chelating Agents; Maternal Age; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Triazoles | 2011 |
Absence of teratogenicity of deferasirox treatment during pregnancy in a thalassaemic patient.
Topics: Adult; Benzoates; beta-Thalassemia; Deferasirox; Female; Humans; Infant, Newborn; Iron Chelating Agents; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Teratogens; Triazoles | 2011 |